These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17483542)

  • 1. Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients.
    Koh KK; Quon MJ; Lee Y; Han SH; Ahn JY; Chung WJ; Kim JA; Shin EK
    Eur Heart J; 2007 Jun; 28(12):1440-7. PubMed ID: 17483542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Lee Y; Shin EK
    Int J Cardiol; 2006 Mar; 108(1):96-100. PubMed ID: 16246439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine improves endothelial function and metabolic parameters in patients with hypertension.
    Koh KK; Han SH; Ahn JY; Chung WJ; Lee Y; Shin EK
    Int J Cardiol; 2009 Mar; 133(1):23-31. PubMed ID: 18199500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Kim JA; Lee Y; Shin EK
    Diabetes Care; 2006 Feb; 29(2):195-201. PubMed ID: 16443859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
    Koh KK; Quon MJ; Han SH; Lee Y; Kim SJ; Koh Y; Shin EK
    Int J Cardiol; 2010 Apr; 140(1):73-81. PubMed ID: 19059660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Kang MH; Ahn TH; Choi IS; Shin EK
    Circulation; 2004 Dec; 110(24):3687-92. PubMed ID: 15569835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria.
    Morgan T; Anderson A; Bertram D; MacInnis RJ
    J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):64-71. PubMed ID: 15295717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension--the Nifedipine and Candesartan Combination (NICE-Combi) Study.
    Fujikawa K; Hasebe N; Kikuchi K;
    Hypertens Res; 2005 Jul; 28(7):585-91. PubMed ID: 16335887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension.
    Koh KK; Quon MJ; Han SH; Lee Y; Park JB; Kim SJ; Koh Y; Shin EK
    Int J Cardiol; 2011 Feb; 146(3):319-25. PubMed ID: 19651449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
    J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
    Karlson BW; Zetterstrand S; Olofsson B; Elmfeldt D
    Blood Press; 2009; 18(3):149-56. PubMed ID: 19462314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.
    Schram MT; van Ittersum FJ; Spoelstra-de Man A; van Dijk RA; Schalkwijk CG; Ijzerman RG; Twisk JW; Stehouwer CD
    J Hum Hypertens; 2005 Jun; 19(6):429-37. PubMed ID: 15647778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus.
    Kaku K; Enya K; Sugiura K; Totsuka N
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():73-84. PubMed ID: 22106979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.